Michael J. Fox Returns to Television in ‘Shrinking’, Reflects on Legacy and Advocacy


Michael J. Fox Returns to Television in ‘Shrinking’, Reflects on Legacy and Advocacy

michael j fox

SYDNEY, 30 January 2026 – Iconic actor and Parkinson’s disease advocate Michael J. Fox has made a celebrated return to television, appearing in a recurring role on the third season of Apple TV+’s acclaimed series “Shrinking”. The 64-year-old star’s comeback, his first acting role since retiring in 2020, has sparked widespread discussion about his health, his legacy, and his unwavering commitment to raising funds and awareness for Parkinson’s research.

A Purposeful Return to the Screen

Fox joins the cast of “Shrinking” as Jerry, a patient living with Parkinson’s disease who forms a connection with Harrison Ford’s character, Dr. Paul Rhoades. The role marks a reunion with series co-creator Bill Lawrence, with whom Fox worked on “Spin City”. In interviews promoting the show, Fox revealed his decision to retire six years ago was “non-emotional” and clarified that his return is “not the beginning of any campaign to reestablish my career.” He stated he was simply moved by the quality of the show and wanted to be part of it. A poignant clip from the season premiere features Fox’s character defiantly stating, “F*** Parkinson’s,” a line that has resonated deeply with audiences.

Key Facts & Recent Developments

AspectDetails
Current ProjectRecurring role as Jerry in Season 3 of “Shrinking” on Apple TV+.
Health AdvocacyFounded The Michael J. Fox Foundation, which has raised over A$2.5 billion for Parkinson’s research.
Recent CommentaryStated he does not “struggle with his legacy,” focusing instead on living his “best life.”
Political CritiqueRecently criticised former US President Donald Trump for a lack of federal involvement in Parkinson’s research, noting his foundation directs more funds than the US government.
Research CollaborationThe Michael J. Fox Foundation is collaborating with Nautilus Biotechnology and Weill Cornell Medicine-Qatar on advanced proteomics research for Parkinson’s.

Legacy, Life, and Continued Fight

Despite his monumental impact through film, television, and philanthropy, Fox has been candid about not dwelling on his legacy. “My business is to live my best life,” he told Entertainment Weekly. Diagnosed with early-onset Parkinson’s at age 29 in 1991, Fox has become the world’s most recognisable face of the disease. His advocacy work remains fiercely active. In a recent interview, he expressed frustration that his pleas to the Trump administration for greater government involvement in Parkinson’s research went unanswered, starkly highlighting the disparity between private foundation funding and federal support.

Frequently Asked Questions

Why did Michael J. Fox return to acting?

Fox stated he was profoundly moved by the writing and depth of character in “Shrinking” and wanted to be part of the project for its own sake, not to restart his career.

What is the status of The Michael J. Fox Foundation?

The foundation remains a global leader in Parkinson’s research funding, having raised more than A$2.5 billion. It continues to forge new research partnerships, such as a recent collaboration on single-molecule proteomics.

Does Michael J. Fox have any upcoming projects?

His current focus is his role on “Shrinking”. He has also done voice work recently, including a role in “Zootopia 2”.